Publikationen von M. Ising

Bschor, T.; Baethge, C.; Adli, M.; Eichmann, U.; Ising, M.; Uhr, M.; Modell, S.; Künzel, H.; Müller-Oerlinghausen, B.; Bauer, M.: Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder. Journal of Psychiatric Research 37 (2), S. 135 - 143 (2003)

Steiger, A.; Schmid, D. A.; Ising, M.; Uhr, M.; Weikel, J. C.; Held, K.: Opposite changes of nocturnal ghrelin and leptin levels during treatment of depression with mirtazapine. Naunyn-Schmiedebergs Archives of Pharmacology 367 (Suppl. Suppl. 1), S. R111 - R111 (2003)

Bschor, T.; Baethge, C.; Adli, M.; Eichmann, U.; Ising, M.; Uhr, M.; Müller-Oerlinghausen, B.; Bauer, M.: Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Depression and Anxiety 17 (1), S. 43 - 48 (2003)

Ising, M.: CFA as a method for genetic association studies in complex diseases. Psychology Science 45 (2), S. 236 - 240 (2003)

Janke, W.; Ising, M.: Prediction of placebo responses by multiple regression methods and CFA. Re-analysis of an experiment conducted by W. Janke between 1963 and 1966. Psychology Science 45 (2), S. 223 - 235 (2003)

Ising, M.; Adena, S.; Binder, E.; Huber, J.; Holsboer, F.; Modell, S.: Somatic complaints and somatosensory ERPs as vulnerability markers for affective disorders. American Journal of Medical Genetics 114 (7), S. 763 - 764 (2002)

Kuenzel, H. E.; Binder, E. B.; Nickel, T.; Ising, M.; Fuchs, B.; Modell, S.; Holsboer, F.: The combined dexamethasone-suppression/corticotropin-releasing-hormone(CRH) stimulation test, a possible endophenotype for major depression? American Journal of Medical Genetics 114 (7), S. 766 - 767 (2002)

Ising, M.; Adena, S.; Binder, E.; Huber, J.; Holsboer, J.; Modell, S.: Auditory and somatosensory evoked potentials as vulnerability markers for affective disorders. Journal of Psychophysiology 16 (4), S. 241 - 242 (2002)

Zobel, A. W.; Nickel, T.; Sonntag, A.; Uhr, M.; Holsboer, F.; Ising, M.: Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. Journal of Psychiatric Research 35, S. 83 - 94 (2001)

Zobel, A. W.; Nickel, T.; Künzel, H. E.; Ackl, N.; Sonntag, A.; Ising, M.; Holsboer, F.: Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R 121919 in major depression: The first 20 patients treated. Journal of Psychiatric Research 34, S. 171 - 181 (2000)

Keck, M. E.; Egli, S.; Ising, M.: Moderne Depressionsbehandlung. In: Das Depressions-Buch für Pflege- und Gesundheitsberufe Menschen mit Depressionen gekonnt pflegen und behandeln, S. 49 - 73 (Hg. Hax-Schoppenhorst, T.; Jünger, S.). Hogrefe, Bern (2016)

Ising, M.: Stresshormonregulation und Depressionsrisiko - Perspektiven für die antidepressive Behandlung. In: Jahrbuch. Forschungsberichte und Publikationen 2011/12, 8 p. (Hg. der Wissenschaften, M.-P.-G. z. F.). Max-Planck-Gesellschaft zur Förderung der Wissenschaften, München (2012)

Ising, M.; Lauer, C. J.; Holsboer, F.; Modell, S.: Münchner Vulnerabilitätsstudie: Beitrag von "High-risk"-Studien zur Verlaufsforschung. In: Psychopathologie im Längsschnitt: Methoden, Analyse, Bewertung, S. 148 - 160 (Hg. Soyka, M.; Möller, H.-J.; Wittchen, H.-U.). ecomed, Landsberg/Lech (2003)

Ising, M.; Scheuer, S.; Belcredi, P.; Uhr, M.; Holsboer, F.: Perspective of Personalized Drug Treatment in Depression. 73rd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), New York, NY, 10. Mai 2018 - 12. Mai 2018. BIOLOGICAL PSYCHIATRY 83 (9, Suppl.), S74, S. S375 - S376 (2018)

Faber, H.; Leistner, S.; Ising, M.: Cross-sectional study in German MS patients reveals unmet needs with regard to psychiatric comorbidity. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, FRANCE, 25. Oktober 2017 - 28. Oktober 2017. MULTIPLE SCLEROSIS JOURNAL 23 (3, Suppl.), P883, S. 457 - 457 (2017)

Iurato, S.; Carrillo-Roa, T.; Arloth, J.; Czamara, D.; Ising, M.; Lucae, S.; Müller-Myhsok, B.; Binder, E.; Erhardt, A.: SEX-SPECIFIC DNA METHYLATION SIGNATURES IN PANIC DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 3), T24, S. S446 - S447 (2017)

Iurato, S.; Carrillo-Roa, T.; Ising, M.; Lucae, S.; Binder, E.; Erhardt, A.: EPIGENOME-WIDE ASSOCIATION STUDY (EWAS) IN A PANIC DISORDER COHORT. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 2), Su48, S. S231 - S231 (2017)

Ising, M.; Belcredi, P.; Lucae, S.; Tontsch, A.; Namendorf, C.; Uhr, M.; Holsboer, F.; Rex-Haffner, M.; Simulionyte, E.; Hebib, S. et al.; Gruber Oliver, O.; Behler, N.; Nenov-Matt, T.; Schuele, C.; Manook, A.; Heckel, B.; Baghai, T.; Rupprecht, R.: GENOMIC AND IMMUNOLOGICAL BIOMARKERS FOR PREDICTING TREATMENT OUTCOME IN DEPRESSION. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 28, S. i314 - i314. (2025)

Rubens, M.; Bruenig, D.; Adams, J.; Shakespeare-Finch, J.; Maihofer, A.; Nievergelt, C. M.; Ising, M.; Mehta, D.: LONGITUDINAL BIOPSYCHOSOCIAL MARKERS OF POSTTRAUMATIC OUTCOMES IN A DIVERSE GROUP OF EMERGENCY RESPONDERS. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 87, S. 139 - 140. World Congress of Psychiatric Genetics (WCPG), Singapore, SINGAPORE, 15. Oktober 2024 - 19. Oktober 2024. (2024)

von Kaenel, R.; Merz, F.; Pfister, H.; Brueckl, T.; Zimmermann, P.; Uhr, M.; Holsboer, F.; Höhne, N.; Ising, M.: Evidence for an enhanced procoagulant state in remitted major depression. In WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 21 (10), S. 766 - 774. (2020)